MSK
Search
- Page Path
- HOME > Search
Journal Article
- Bedaquiline susceptibility test for totally drug-resistant tuberculosis Mycobacterium tuberculosis
- Ji-Chan Jang , Yong-Gyun Jung , Jungil Choi , Hyunju Jung , Sungweon Ryoo
- J. Microbiol. 2017;55(6):483-487. Published online April 20, 2017
- DOI: https://doi.org/10.1007/s12275-017-6630-1
- 47 View
- 0 Download
- 6 Crossref
-
Abstract
- This study aimed to provide information that bedaquilline is significantly effective for treatment of totally drug resistant (TDR) Mycobacterium tuberculosis that shows resistant to all first- and second-line drugs-using an innovative disc agarose channel (DAC) system. Time-lapse images of single bacterial cells under culture conditions with different concentrations of bedaquiline were analysed by image processing software to determine minimum inhibitory concentrations (MICs). Bedaquiline inhibited the growth of TDR M. tuberculosis strains, with MIC values ranging from 0.125 to 0.5 mg/L. The results of the present study demonstrate that bedaquiline, newly approved by the United States Food and Drug Admi-nistration (FDA), may offer therapeutic solutions for TDR -TB.
-
Citations
Citations to this article as recorded by
- Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis
Rong Yao, Bin Wang, Lei Fu, Lei Li, Kejun You, Yong-Guo Li, Yu Lu, Luiz Pedro Sorio de Carvalho
Microbiology Spectrum.2022;[Epub] CrossRef - Recent developments, challenges and future prospects in advanced drug delivery systems in the management of tuberculosis
Nitin Verma, Vimal Arora, Rajendra Awasthi, Yinghan Chan, Niraj Kumar Jha, Komal Thapa, Talha Jawaid, Mehnaz Kamal, Gaurav Gupta, Gang Liu, Keshav Raj Paudel, Philip Michael Hansbro, Brian Gregory George Oliver, Sachin Kumar Singh, Dinesh Kumar Chellappan
Journal of Drug Delivery Science and Technology.2022; 75: 103690. CrossRef -
In vitro activity of bedaquiline against Mycobacterium avium complex
Vitaly Litvinov, Marina Makarova, Dmitry Kudlay, Nikolai Nikolenko, Julia Mikhailova
Journal of Medical Microbiology .2021;[Epub] CrossRef - Problems of drug resistance of M. tuberculosis
V. I. Litvinov, E. Yu. Nosova
Tuberculosis and socially significant diseases.2021; 9(2): 70. CrossRef - Bedaquiline and linezolid MIC distributions and epidemiological cut-off values forMycobacterium tuberculosisin the Latin American region
Beatriz Lopez, Rosangela Siqueira de Oliveira, Juliana M W Pinhata, Erica Chimara, Edson Pacheco Ascencio, Zully M Puyén Guerra, Ingrid Wainmayer, Norberto Simboli, Mirtha Del Granado, Juan Carlos Palomino, Viviana Ritacco, Anandi Martin
Journal of Antimicrobial Chemotherapy.2019; 74(2): 373. CrossRef - Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon
Zubair Shanib Bhat, Muzafar Ahmad Rather, Mubashir Maqbool, Zahoor Ahmad
Biomedicine & Pharmacotherapy.2018; 103: 1733. CrossRef
- Sudapyridine (WX-081), a Novel Compound against Mycobacterium tuberculosis
First
Prev
TOP
